Advertisement

help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robertson, M. J.
Right arrow Articles by Ritz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, M. J.
Right arrow Articles by Ritz, J.
The Oncologist, Vol. 1, No. 1_2, 88–97, February 1996
© 1996 AlphaMed Press

Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment

Michael J. Robertson, Jerome Ritz

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and the Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Correspondence: Michael J. Robertson, M.D., Division of Hematologic Malignancies, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. Telephone: 617-632-3768; Fax: 617-632-5167; e-mail: michael_robertson{at}dfci.harvard.edu

Interleukin 12 is a heterodimeric cytokine that has potent effects on innate and adaptive immunity. Interleukin 12 induces interferon {gamma} secretion by T cells and natural killer cells, enhances the proliferation of activated T cells and natural killer cells, augments the cytolytic activity of cytotoxic T lymphocytes and natural killer cells, and supports the differentiation of Th1 helper effector cells. Interleukin 12 stimulates in vitro antitumor activity of lymphocytes from patients with cancer and in vivo antitumor activity in many murine tumor models. Current data indicate that CD4 T cells, CD8 T cells, natural killer cells and interferon {gamma} may contribute to the antitumor effects of interleukin 12 therapy. However, further investigation is required to elucidate the precise mechanisms involved in the antitumor activity of interleukin 12.

Key Words. Interleukin 12 (IL-12) • Immunotherapy • Biologic therapy • Cytokine therapy • Tumor immunology • Antitumor immunity




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. D. Sharma, S. M. Meeran, N. Katiyar, G. B. Tisdale, N. Yusuf, H. Xu, C. A. Elmets, and S. K. Katiyar
IL-12 deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz(a)anthracene-initiated mouse skin through inhibition of inflammation
Carcinogenesis, November 1, 2009; 30(11): 1970 - 1977.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Chen, J. Lu, N. Srinivasan, B. K. H. Tan, and S. H. Chan
Polysaccharide-Protein Complex from Lycium barbarum L. Is a Novel Stimulus of Dendritic Cell Immunogenicity
J. Immunol., March 15, 2009; 182(6): 3503 - 3509.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Meeran, S. Katiyar, C. A. Elmets, and S. K. Katiyar
Interleukin-12 Deficiency Is Permissive for Angiogenesis in UV Radiation-Induced Skin Tumors
Cancer Res., April 15, 2007; 67(8): 3785 - 3793.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. R. Coward, A. Marei, A. Yang, M. M. Vasa-Nicotera, and S. C. Chow
Statin-Induced Proinflammatory Response in Mitogen-Activated Peripheral Blood Mononuclear Cells through the Activation of Caspase-1 and IL-18 Secretion in Monocytes
J. Immunol., May 1, 2006; 176(9): 5284 - 5292.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. M. Meeran, S. K. Mantena, S. Meleth, C. A. Elmets, and S. K. Katiyar
Interleukin-12-deficient mice are at greater risk of UV radiation-induced skin tumors and malignant transformation of papillomas to carcinomas.
Mol. Cancer Ther., April 1, 2006; 5(4): 825 - 832.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Meeran, S. K. Mantena, and S. K. Katiyar
Prevention of Ultraviolet Radiation-Induced Immunosuppression by (-)-Epigallocatechin-3-Gallate in Mice Is Mediated through Interleukin 12-Dependent DNA Repair.
Clin. Cancer Res., April 1, 2006; 12(7): 2272 - 2280.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
H. Kasai, L. M. He, M. Kawamura, P. T. Yang, X. W. Deng, M. Munkanta, A. Yamashita, H. Terunuma, M. Hirama, I. Horiuchi, et al.
IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR)
Evid. Based Complement. Altern. Med., December 1, 2004; 1(3): 259 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. N. Baxevanis, A. D. Gritzapis, and M. Papamichail
In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18
J. Immunol., September 15, 2003; 171(6): 2953 - 2959.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Gorschluter, C. Ziske, A. Glasmacher, and I. G. H. Schmidt-Wolf
Current Clinical and Laboratory Strategies to Augment the Efficacy of Immunotherapy in Multiple Myeloma
Clin. Cancer Res., August 1, 2001; 7(8): 2195 - 2204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Smyth, M. Taniguchi, and S. E. A. Street
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent
J. Immunol., September 1, 2000; 165(5): 2665 - 2670.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. M. Siders, P. W. Wright, J. A. Hixon, W. G. Alvord, T. C. Back, R. H. Wiltrout, and R. G. Fenton
T Cell- and NK Cell-Independent Inhibition of Hepatic Metastases by Systemic Administration of an IL-12-Expressing Recombinant Adenovirus
J. Immunol., June 1, 1998; 160(11): 5465 - 5474.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 1996 by AlphaMed Press.
Advertisement